Article info
PDFClinical and epidemiological research
Concise report
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
- Correspondence to Joel M Kremer, Center for Rheumatology, Albany Medical College, 1367 Washington Ave, Albany, NY 12206, USA; jkremer{at}joint-docs.com
Citation
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
Publication history
- Accepted June 11, 2011
- First published September 5, 2011.
Online issue publication
November 02, 2019
Web Only Data
Files in this Data Supplement:
Web Only Data
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This paper is freely available online under the BMJ Journals unlocked scheme, see http://ard.bmj.com/info/unlocked.dtl